-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Financial Contrast: Zenvia (NASDAQ:ZENV) & Definitive Healthcare (NASDAQ:DH)
Financial Contrast: Zenvia (NASDAQ:ZENV) & Definitive Healthcare (NASDAQ:DH)
Definitive Healthcare (NASDAQ:DH – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.
Analyst Recommendations
This is a summary of current ratings and price targets for Definitive Healthcare and Zenvia, as provided by MarketBeat.
Get Definitive Healthcare alerts:| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Definitive Healthcare | 0 | 5 | 4 | 0 | 2.44 |
| Zenvia | 0 | 4 | 0 | 0 | 2.00 |
Definitive Healthcare presently has a consensus target price of $19.11, indicating a potential upside of 73.90%. Zenvia has a consensus target price of $2.63, indicating a potential upside of 128.26%. Given Zenvia's higher probable upside, analysts plainly believe Zenvia is more favorable than Definitive Healthcare.
Valuation & Earnings
This table compares Definitive Healthcare and Zenvia's top-line revenue, earnings per share (EPS) and valuation.| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Definitive Healthcare | $166.15 million | 6.95 | -$51.02 million | ($0.27) | -40.70 |
| Zenvia | $113.49 million | 0.42 | -$8.27 million | ($0.25) | -4.60 |
Zenvia has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Zenvia, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
35.7% of Zenvia shares are owned by institutional investors. 17.5% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Definitive Healthcare and Zenvia's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Definitive Healthcare | -12.56% | 0.69% | 0.49% |
| Zenvia | -5.59% | -3.71% | -2.36% |
Risk & Volatility
Definitive Healthcare has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.
About Definitive Healthcare
(Get Rating)
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
About Zenvia
(Get Rating)
Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
Definitive Healthcare (NASDAQ:DH – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.
确定医疗(纳斯达克：HD-GET评级)和捷维亚(纳斯达克：ZENV-GET评级)都是小盘医疗公司，但哪一项业务更优越？我们将根据这两家公司的估值、盈利能力、股息、分析师建议、收益、机构所有权和风险等方面的实力进行对比。
Analyst Recommendations
分析师建议
This is a summary of current ratings and price targets for Definitive Healthcare and Zenvia, as provided by MarketBeat.
这是由MarketBeat提供的最终医疗保健和Zenvia的当前评级和目标价的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Definitive Healthcare | 0 | 5 | 4 | 0 | 2.44 |
| Zenvia | 0 | 4 | 0 | 0 | 2.00 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 权威医疗保健 | 0 | 5 | 4 | 0 | 2.44 |
| Zenvia | 0 | 4 | 0 | 0 | 2.00 |
Definitive Healthcare presently has a consensus target price of $19.11, indicating a potential upside of 73.90%. Zenvia has a consensus target price of $2.63, indicating a potential upside of 128.26%. Given Zenvia's higher probable upside, analysts plainly believe Zenvia is more favorable than Definitive Healthcare.
Finitive Healthcare目前的共识目标价为19.11美元，表明潜在上行空间为73.90%。Zenvia的一致目标价为2.63美元，表明潜在上涨128.26%。考虑到Zenvia更有可能的上行空间，分析师们显然认为Zenvia比Defintive Healthcare更有利。
Valuation & Earnings
估值与收益
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Definitive Healthcare | $166.15 million | 6.95 | -$51.02 million | ($0.27) | -40.70 |
| Zenvia | $113.49 million | 0.42 | -$8.27 million | ($0.25) | -4.60 |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| 权威医疗保健 | 1.6615亿美元 | 6.95 | -5,102万元 | ($0.27) | -40.70 |
| Zenvia | 1.1349亿美元 | 0.42 | -827万元 | ($0.25) | -4.60 |
Zenvia has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Zenvia, indicating that it is currently the more affordable of the two stocks.
与Defintive Healthcare相比，Zenvia的收入较低，但收益较高。最终医疗保健的市盈率低于Zenvia，这表明它目前是两只股票中更负担得起的一只。
Insider and Institutional Ownership
内部人与机构持股
35.7% of Zenvia shares are owned by institutional investors. 17.5% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Zenvia 35.7%的股份由机构投资者持有。最终医疗保健公司17.5%的股份由公司内部人士持有。强大的机构持股表明，对冲基金、捐赠基金和大型基金经理相信，从长期来看，一只股票的表现将好于大盘。
Profitability
盈利能力
This table compares Definitive Healthcare and Zenvia's net margins, return on equity and return on assets.
此表比较了Desitive Healthcare和Zenvia的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Definitive Healthcare | -12.56% | 0.69% | 0.49% |
| Zenvia | -5.59% | -3.71% | -2.36% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 权威医疗保健 | -12.56% | 0.69% | 0.49% |
| Zenvia | -5.59% | -3.71% | -2.36% |
Risk & Volatility
风险与波动性
Definitive Healthcare has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.
Finitive Healthcare的贝塔系数为0.4，表明其股价的波动性比标准普尔500指数低60%。相比之下，Zenvia的贝塔系数为1.56，这表明其股价的波动性比标准普尔500指数高56%。
About Definitive Healthcare
关于终极医疗保健
(Get Rating)
(获取评级)
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Finitive Healthcare Corp.及其子公司在美国提供医疗保健商业情报。其解决方案提供有关医疗保健提供者及其活动的信息，以帮助该领域的客户，范围从产品开发到上市规划，以及销售和营销执行。该公司的平台提供16个智能模块，涵盖销售、营销、临床研究和产品开发、战略、人才获取和医生网络管理等功能领域。它为生物制药和医疗器械公司、医疗保健信息技术公司和医疗保健提供者提供服务；以及其他多元化公司，包括医疗保健生态系统中的人员和商业房地产公司、金融机构和其他组织。Finitive Healthcare Corp.成立于2011年，总部设在马萨诸塞州弗雷明翰。
About Zenvia
关于Zenvia
(Get Rating)
(获取评级)
Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.
Zenvia Inc.提供客户体验交流平台，使企业能够为其最终客户在其生命周期中跨越一系列B2C垂直市场创造独特的旅程。Zenvia Inc.的总部设在圣保罗。
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
获得权威医疗日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对最终医疗保健及相关公司的评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧